Fragment Screening, Pharmacokinetics and Presentation

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Fragment Screening

Pharmacokinetics

Presentation

SARS-CoV-2 Protease Inhibitors: An Attractive Approach for Treating COVID-19

PerkinElmer

JUNE 3, 2022

2 In the present study, the researchers report that PF-07321332 demonstrated potent inhibition in FRET M pro assays representing M pro from all coronavirus types known to infect humans. The second virtual screen focused on optimization of a hit from a previous crystallographic fragment screen.

Fragment Screening

Fragment Screening Clinical Trials Vaccine Pharmacokinetics

SARS-CoV-2 main protease. Crowdsourcing, peptidomimetics and fragments

Molecular Design

JULY 18, 2020

I’ve been looking at the published inhibitors shown below in Chart 1 (which exhibit antiviral activity and have been subjected to pharmacokinetic and toxicological evaluation) and have written some notes on mapping the structure-activity relationship for compounds like these.

Biochemical Assays

Biochemical Assays Fragment Screening Pharmacokinetics Drugs

Drug Discovery Digest

SARS-CoV-2 Protease Inhibitors: An Attractive Approach for Treating COVID-19

SARS-CoV-2 main protease. Crowdsourcing, peptidomimetics and fragments

Stay Connected